ENDRA Life Sciences (NDRA) Cash & Equivalents Growth (1y) (2017 - 2026)
ENDRA Life Sciences (NDRA) Cash & Equivalents Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -11.19% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 47.04% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 19.65% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.60% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.38% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 12.96% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 11.35% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -16.86% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 96.24% |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | -82.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.74% |
| Dec 31, 2025 | -76.39% |
| Sep 30, 2025 | -83.27% |
| Jun 30, 2025 | -71.74% |
| Mar 31, 2025 | 81.98% |
| Dec 31, 2024 | 13.96% |
| Sep 30, 2024 | 42.30% |
| Jun 30, 2024 | 32.81% |
| Mar 31, 2024 | -51.82% |
| Dec 31, 2023 | -42.04% |
| Sep 30, 2023 | -58.40% |
| Jun 30, 2023 | -57.27% |
| Mar 31, 2023 | -66.95% |
| Dec 31, 2022 | -48.33% |
| Sep 30, 2022 | -32.03% |
| Jun 30, 2022 | -19.69% |
| Mar 31, 2022 | -57.68% |
| Dec 31, 2021 | 30.91% |
| Sep 30, 2021 | 210.90% |
| Jun 30, 2021 | 1,776.04% |